FilingReader Intelligence
Gland Pharma secures Danish GMP compliance for aseptic powder
July 11, 2025 at 07:05 PM UTC•By FilingReader AI
Gland Pharma's Pashamylaram facility has received Good Manufacturing Practices compliance certification from the Danish Medicines Agency for aseptically prepared powder for injection, infusion, and inhalation.
The approval covers manufacturers outside the European Economic Area and is critical for marketing authorizations in European markets.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:GLAND•Bombay Stock Exchange
News Alerts
Get instant email alerts when Gland Pharma publishes news
Free account required • Unsubscribe anytime